Canada has invested in science. Now it must capture the economic benefits

The challenge now is to turn our strengths into globally competitive companies that retain more intellectual property, jobs, and economic value in Canada.

Industry Minister Mélanie Joly. Government does not need to finance every stage of biotechnology development but targeted early support can reduce risk until larger pools of private capital can take over, write Cate Murray, Maura Campbell, Jeff Smirle, and Penny Walsh. The Hill Times photograph by Andrew Meade

Opinion

BY CATE MURRAY, MAURA CAMPBELL, JEFF SMIRLE, PENNY WALSH

September 16, 2026

What if a child born with a faulty electrical system in her heart could one day receive living heart cells instead of relying on a battery-powered pacemaker for life?

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Tuesdays: Innovation & Industry Newsletter

The policies, decisions, and people working on investment and regulation in the industry and innovation realm.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy

FOLLOW THE HILL TIMES: